Excluding pregnancy among women initiating antiretroviral therapy: efficacy of a family planning job aid

Torpey, Kwasi; Mwenda, Lona; Kabaso, Mushota; Malebe, Thierry; Makelele, Patrick; Mwema, Francis; Phiri, Henry; Mukundu, Jonathan; Weaver, Mark A; Stanback, John
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p249
Academic Journal
Background: Guidelines for initiating ART recommend pregnancy testing, typically a urine test, as part of the basic laboratory package. The principal reason for this recommendation is that Efavirenz, a first-line antiretroviral medication, has the potential of causing birth defects when used in the first trimester of pregnancy and is therefore contraindicated for use by pregnant women. Unfortunately, in many African countries pregnancy tests are not routinely provided or available in ART clinics, and, when available outside clinics, are often not affordable for clients. Recently, the World Health Organization added a family planning job aid called the 'pregnancy checklist,' developed by researchers at Family Health International, as a recommended tool for screening new ART clients to exclude pregnancy. Although the checklist has been validated for excluding pregnancy among family planning clients, there are no data on its efficacy among ART clients. This study was conducted to assess the clinical performance of a job aid to exclude pregnancy among HIV positive women initiating ART. Methods: Non-menstruating women eligible for ART were enrolled from 20 sites in four provinces in Zambia. The pregnancy checklist was administered followed by a urine pregnancy test as a reference standard. Sensitivity, specificity, and positive and negative predictive values were estimated. Results: Of the 200 women for whom the checklist ruled out pregnancy, 198 were not pregnant, for an estimated negative predictive value of 99%. The sensitivity of the checklist was 90.0%, and specificity was 38.7%. Among the women, 416 out of 534 (77.9%) did not abstain from sex since their last menses. Only 72 out of the 534 women (13.4%) reported using reliable contraception. Among the 416 women who did not abstain, 376 (90.4%) did not use reliable contraception. Conclusion: The pregnancy checklist is effective for excluding pregnancy in many women initiating ART, but its moderate sensitivity and specificity precludes its use to completely replace pregnancy testing. Its use should be encouraged in low resource settings where pregnancy tests are unavailable or must be rationed. Family planning methods should be available and integrated into ART clinics.


Related Articles

  • PREGNANCY. TATUM IV, WILLIAM O.; KAPLAN, PETER W.; PIERRE, JALLON // Epilepsy A to Z: A Concise Encyclopedia;2009, p265 

    An encyclopedia entry for "pregnancy" is presented. More than 1.1 million women in the U.S. have epilepsy, including pregnant women with epilepsy (WWE). Epileptic women conceive with increased frequency. Also, 40% of pregnancies are unplanned. Epilepsy serves as an individual risk factor for...

  • Folic acid supplements in pregnancy and early childhood respiratory health. S E Håberg // Archives of Disease in Childhood;Mar2009, Vol. 94 Issue 3, p180 

    BACKGROUND: Folate supplementation is recommended for pregnant women to reduce the risk of congenital malformations. Maternal intake of folate supplements during pregnancy might also influence childhood immune phenotypes via epigenetic mechanisms. OBJECTIVE: To investigate the relationship...

  • Treatment of asthma during pregnancy: more solid evidence needed. Cazzola, Mario; Matera, Maria Gabriella // Thorax;Nov2008, Vol. 63 Issue 11, p944 

    The article reports on the need of a more solid evidence leading to treatment of asthma during pregnancy. The author explains the association of risks in the development of congenital malformations with pregnant women undergoing asthma medications. An important study showed evidence of safe...

  • Midwife is first-choice for childbearing women.  // World of Irish Nursing & Midwifery;Apr2006, Vol. 14 Issue 4, p17 

    The article reports that the International Confederation of Midwives has recognized a need to identify the midwife as the most appropriate healthcare professional for women during pregnancy, childbirth and the postnatal period in Ireland. The group believes that midwives and midwifery skills are...

  • PREGNANCY HOTLINE. Landau, Meryl Davids // Self;Oct2002, Vol. 24 Issue 10, p98 

    Presents news related to pregnancy as of October 2002. Beauty tips for pregnant women; Labor room tips; Fertility problems of women.

  • Efavirenz use during pregnancy and for women of child-bearing potential. Chersich, Matthew F; Urban, Michael F; Venter, Francois WD; Wessels, Tina; Krause, Amanda; Gray, Glenda E; Luchters, Stanley; Viljoen, Dennis L // AIDS Research & Therapy;2006, Vol. 3, p11 

    Background: Efavirenz is the preferred non-nucleoside reverse transcriptase inhibitor for first-line antiretroviral treatment in many countries. For women of childbearing potential, advantages of efavirenz are balanced by concerns that it is teratogenic. This paper reviews evidence of efavirenz...

  • Advocacy group: Poor resource distribution preventing many pregnant women from receiving ART.  // Infectious Disease News;Jun2009, Vol. 22 Issue 6, p12 

    The article focuses on a report issued by the International Treatment Preparedness Coalition concerning the poor resource distribution of antiretroviral therapy (ART) for pregnant women.

  • Amniotic band syndrome. Rushton, D.I. // British Medical Journal (Clinical Research Edition);3/19/1983, Vol. 286 Issue 6369, p919 

    Focuses on the incidence of amniotic band syndrome in live births. Correlation between the bands and fetal malformations; Categories of fetal malformations; Necessity for ultrasound to detect the syndrome in early pregnancy.

  • Second Study Links Paxil To Birth Defects.  // RN;Feb2006, Vol. 69 Issue 2, p70 

    Focuses on the findings of the U.S. Food & Drug Administration (FDA) study "FDA Advising of Risk of Birth Defects With Paxil" in 2005. Risk of having a heart defect for babies born to women who had taken the antidepressant paroxetine Paxil, during the first trimester of pregnancy; Heart...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics